Reporting of post-protocol therapies in metastatic breast cancer registration clinical trials: A systematic review

Shachar, S. S., Korzets, Y., Shepshelovich, D., Zlothover, N., Amir, E., Tibau, A., & Goldvaser, H. (2024). Reporting of post-protocol therapies in metastatic breast cancer registration clinical trials: A systematic review. Cancer Treatment Reviews, 122, 102666. https://doi.org/10.1016/j.ctrv.2023.102666
Authors:
Shlomit Strulov Shachar
Yasmin Korzets
Daniel Shepshelovich
Noa Zlothover
Eitan Amir
Ariadna Tibau
Hadar Goldvaser
Affiliated Authors:
Daniel Shepshelovich
Columbia Affiliation:
Subjects:
Breast Neoplasms (MeSH)
Author Keywords:
drug approval, clinical trials
fda
metastatic breast cancer
post progression treatment
elink
Publication Type:
Article
Unique ID:
10.1016/j.ctrv.2023.102666
PMID:
38064877
DOI:
10.1016/j.ctrv.2023.102666
Journal:
Cancer Treatment Reviews
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: